+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Victoza"

From
Diabetes Drug Intelligence Center 2012-2023 - Product Thumbnail Image

Diabetes Drug Intelligence Center 2012-2023

  • Report
  • May 2024
  • Global
From
From
From
From
From
From
From
From
US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 500 Pages
  • United States
From
From
From
From
From
From
From
From
Loading Indicator

Victoza is a prescription medication used to treat obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by stimulating the release of insulin and suppressing appetite. It is typically prescribed to people who are overweight or obese and have not been able to lose weight through diet and exercise alone. Victoza is usually taken once a day, and it can be used in combination with other anti-obesity drugs. Victoza is one of several anti-obesity drugs available on the market. Other drugs in this class include Saxenda, Contrave, and Belviq. These drugs work by targeting different pathways in the body to help reduce appetite and promote weight loss. The market for anti-obesity drugs is highly competitive, with many companies vying for a share of the market. Some of the major players in this market include Novo Nordisk, Orexigen Therapeutics, Arena Pharmaceuticals, Vivus, and Eisai. Show Less Read more